Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,330,117
  • Shares Outstanding, K 198,229
  • Annual Sales, $ 40 K
  • Annual Income, $ -21,820 K
  • 60-Month Beta 4.43
  • Price/Sales 31.72
  • Price/Cash Flow N/A
  • Price/Book 27.60
Trade OCGN with:

Options Overview

Details
  • Implied Volatility 121.65%
  • Historical Volatility 70.98%
  • IV Percentile 12%
  • IV Rank 7.52%
  • IV High 359.02% on 02/26/21
  • IV Low 102.36% on 07/29/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 3,244
  • Volume Avg (30-Day) 25,155
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 240,911
  • Open Int (30-Day) 314,947

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.03
  • Number of Estimates 3
  • High Estimate -0.03
  • Low Estimate -0.04
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +84.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.11 +11.29%
on 07/15/21
8.29 -17.97%
on 07/06/21
-0.49 (-6.72%)
since 07/02/21
3-Month
5.96 +14.09%
on 06/14/21
16.20 -58.02%
on 05/03/21
-5.87 (-46.33%)
since 04/30/21
52-Week
0.25 +2,618.91%
on 11/02/20
18.77 -63.77%
on 02/08/21
+6.28 (+1,220.13%)
since 07/31/20

Most Recent Stories

More News
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 2, 2021) - , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocugen" or "the Company")...

OCGN : 6.79 (+1.19%)
OCGN, TEDU & HMPT Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

OCGN : 6.79 (+1.19%)
TEDU : 1.9800 (unch)
HMPT : 5.07 (+1.81%)
CLASS ACTION UPDATE for SRAC, OCGN and CRMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

SRAC : 10.00 (unch)
OCGN : 6.79 (+1.19%)
CRMD : 5.99 (+3.10%)
Rosen, Top Ranked Investor Counsel, Encourages Ocugen, Inc. Investors with Losses to Secure Counsel Before Important August 17 Deadline in Securities Class Action - OCGN

New York, New York--(Newsfile Corp. - July 31, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and...

OCGN : 6.79 (+1.19%)
LAWSUITS FILED AGAINST OCGN, HMPT and ATHA - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / July 30, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

OCGN : 6.79 (+1.19%)
HMPT : 5.07 (+1.81%)
ATHA : 9.56 (-0.52%)
SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocugen, Inc. of Class Action Lawsuit and Upcoming Deadline - OCGN

NEW YORK, NY / ACCESSWIRE / July 30, 2021 / Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN) and certain of its officers....

OCGN : 6.79 (+1.19%)
Ocugen (OCGN) Dips More Than Broader Markets: What You Should Know

Ocugen (OCGN) closed at $6.71 in the latest trading session, marking a -1.61% move from the prior day.

OCGN : 6.79 (+1.19%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN

New York, New York--(Newsfile Corp. - July 30, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:

OCGN : 6.79 (+1.19%)
OCGN ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Ocugen, Inc. (NASDAQ:OCGN) for Potential Securities Violations and Breach of Fiduciary Duty

NEW YORK, NY / ACCESSWIRE / July 30, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential securities violations and breach of fiduciary...

OCGN : 6.79 (+1.19%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FREQ, OCGN and BLCT

NEW YORK, NY / ACCESSWIRE / July 30, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders...

FREQ : 8.22 (-1.32%)
OCGN : 6.79 (+1.19%)
BLCT : 5.66 (+1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 7.13
2nd Resistance Point 7.03
1st Resistance Point 6.87
Last Price 6.79
1st Support Level 6.61
2nd Support Level 6.51
3rd Support Level 6.35

See More

52-Week High 18.77
Fibonacci 61.8% 11.70
Fibonacci 50% 9.51
Fibonacci 38.2% 7.32
Last Price 6.79
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar